NO126326B - - Google Patents
Download PDFInfo
- Publication number
- NO126326B NO126326B NO00796/70*[A NO79670A NO126326B NO 126326 B NO126326 B NO 126326B NO 79670 A NO79670 A NO 79670A NO 126326 B NO126326 B NO 126326B
- Authority
- NO
- Norway
- Prior art keywords
- benzodiazepine
- acid
- triazolo
- compounds
- parts
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 claims description 26
- 229940053197 benzodiazepine derivative antiepileptics Drugs 0.000 claims description 18
- 150000003839 salts Chemical class 0.000 claims description 14
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 11
- 229910052739 hydrogen Inorganic materials 0.000 claims description 10
- 239000001257 hydrogen Substances 0.000 claims description 10
- 125000000217 alkyl group Chemical group 0.000 claims description 9
- 125000003545 alkoxy group Chemical group 0.000 claims description 7
- 229910052736 halogen Inorganic materials 0.000 claims description 5
- 150000002367 halogens Chemical class 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 3
- 125000004423 acyloxy group Chemical group 0.000 claims description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims description 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 2
- 125000003310 benzodiazepinyl group Chemical class N1N=C(C=CC2=C1C=CC=C2)* 0.000 claims 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 30
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 28
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 21
- 239000002904 solvent Substances 0.000 description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 17
- 150000001557 benzodiazepines Chemical class 0.000 description 17
- 239000002253 acid Substances 0.000 description 15
- 238000002844 melting Methods 0.000 description 15
- 230000008018 melting Effects 0.000 description 15
- 239000000543 intermediate Substances 0.000 description 13
- -1 inorganic acid salts Chemical class 0.000 description 12
- 229960000583 acetic acid Drugs 0.000 description 10
- 238000000921 elemental analysis Methods 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- 238000001953 recrystallisation Methods 0.000 description 10
- 239000013078 crystal Substances 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- 238000000354 decomposition reaction Methods 0.000 description 7
- 238000001704 evaporation Methods 0.000 description 7
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- 150000001735 carboxylic acids Chemical class 0.000 description 6
- 239000013067 intermediate product Substances 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- GUJAGMICFDYKNR-UHFFFAOYSA-N 1,4-benzodiazepine Chemical compound N1C=CN=CC2=CC=CC=C12 GUJAGMICFDYKNR-UHFFFAOYSA-N 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 238000006266 etherification reaction Methods 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 4
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 4
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 238000006136 alcoholysis reaction Methods 0.000 description 3
- 239000001961 anticonvulsive agent Substances 0.000 description 3
- 229940049706 benzodiazepine Drugs 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- LJIJJCXFWLORDQ-UHFFFAOYSA-N 4-Hydroxy-estazolam Chemical compound C12=CC(Cl)=CC=C2N2C=NN=C2C(O)N=C1C1=CC=CC=C1 LJIJJCXFWLORDQ-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 229940125681 anticonvulsant agent Drugs 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 150000003840 hydrochlorides Chemical class 0.000 description 2
- 229940125723 sedative agent Drugs 0.000 description 2
- 239000000932 sedative agent Substances 0.000 description 2
- WDUQGVUFUFUTIF-UHFFFAOYSA-N (8-chloro-1-methyl-6-phenyl-4h-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl) acetate Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2C(OC(=O)C)N=C1C1=CC=CC=C1 WDUQGVUFUFUTIF-UHFFFAOYSA-N 0.000 description 1
- WLJVXDMOQOGPHL-PPJXEINESA-N 2-phenylacetic acid Chemical compound O[14C](=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-PPJXEINESA-N 0.000 description 1
- GSIGZZKHXAAYOA-UHFFFAOYSA-N 6-phenyl-4h-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine Chemical compound C12=CC=CC=C2N2C=NN=C2CN=C1C1=CC=CC=C1 GSIGZZKHXAAYOA-UHFFFAOYSA-N 0.000 description 1
- WREQLXVWPBXFFI-UHFFFAOYSA-N 8-chloro-1-ethyl-6-phenyl-4h-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine Chemical compound C12=CC(Cl)=CC=C2N2C(CC)=NN=C2CN=C1C1=CC=CC=C1 WREQLXVWPBXFFI-UHFFFAOYSA-N 0.000 description 1
- MBWHYICJBGVYJE-UHFFFAOYSA-N 8-nitro-6-phenyl-4h-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine Chemical compound C=1C([N+](=O)[O-])=CC=C(N2C=NN=C2CN=2)C=1C=2C1=CC=CC=C1 MBWHYICJBGVYJE-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 150000001266 acyl halides Chemical class 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 229960003965 antiepileptics Drugs 0.000 description 1
- 239000002249 anxiolytic agent Substances 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 150000003842 bromide salts Chemical class 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000001244 carboxylic acid anhydrides Chemical class 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- UXTMROKLAAOEQO-UHFFFAOYSA-N chloroform;ethanol Chemical compound CCO.ClC(Cl)Cl UXTMROKLAAOEQO-UHFFFAOYSA-N 0.000 description 1
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 150000008533 dibenzodiazepines Chemical class 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- WHQLQYRFIHPMNA-UHFFFAOYSA-N ethyl acetate;oxolane Chemical compound C1CCOC1.CCOC(C)=O WHQLQYRFIHPMNA-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 150000002905 orthoesters Chemical class 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 150000003568 thioethers Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/20—Nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP44017663A JPS4837280B1 (xx) | 1969-03-08 | 1969-03-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO126326B true NO126326B (xx) | 1973-01-22 |
Family
ID=11950078
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO00796/70*[A NO126326B (xx) | 1969-03-08 | 1970-03-06 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US3907820A (xx) |
| JP (1) | JPS4837280B1 (xx) |
| AT (2) | AT297718B (xx) |
| BE (1) | BE746735A (xx) |
| CH (3) | CH550812A (xx) |
| DE (1) | DE2010884C2 (xx) |
| DK (1) | DK139973B (xx) |
| ES (1) | ES377099A1 (xx) |
| FR (1) | FR2034750B1 (xx) |
| GB (1) | GB1248727A (xx) |
| MY (1) | MY7500010A (xx) |
| NL (1) | NL166023C (xx) |
| NO (1) | NO126326B (xx) |
| PH (2) | PH10048A (xx) |
| SE (2) | SE367201B (xx) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3681343A (en) * | 1971-05-11 | 1972-08-01 | Upjohn Co | 6-phenyl-s-triazolo{8 4,3-a{9 {8 1,4{9 {0 benzodiazepines |
| US3879406A (en) * | 1972-07-13 | 1975-04-22 | Hoffmann La Roche | Preparation of triazolobenzodiazepines |
| JPS5747914B2 (xx) * | 1974-04-12 | 1982-10-13 | ||
| US4588721A (en) * | 1983-09-12 | 1986-05-13 | The Upjohn Company | Treatment of negative symptoms of schizophrenia |
| JPS6193487U (xx) * | 1984-11-22 | 1986-06-17 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3464978A (en) * | 1967-04-21 | 1969-09-02 | Hoffmann La Roche | 1-substituted urea alkyl 1,2-dihydro-1,4-benzodiazepines and benzodiazepin - 2-ones |
| US3498973A (en) * | 1967-06-19 | 1970-03-03 | Hoffmann La Roche | 2,3-dihydro-5-phenyl-1h-1,4-benzodiazepin-3-ol derivatives |
| US3523939A (en) * | 1967-07-03 | 1970-08-11 | Hoffmann La Roche | 5-(2,6-disubstituted phenyl)-1,4-benzodiazepines and methods for their preparation |
-
1969
- 1969-03-08 JP JP44017663A patent/JPS4837280B1/ja active Pending
-
1970
- 1970-02-12 SE SE01824/70A patent/SE367201B/xx unknown
- 1970-02-27 NL NL7002884.A patent/NL166023C/xx not_active IP Right Cessation
- 1970-03-02 DK DK101170AA patent/DK139973B/da unknown
- 1970-03-02 BE BE746735D patent/BE746735A/xx not_active IP Right Cessation
- 1970-03-03 ES ES377099A patent/ES377099A1/es not_active Expired
- 1970-03-05 US US016970A patent/US3907820A/en not_active Expired - Lifetime
- 1970-03-06 CH CH336470A patent/CH550812A/xx not_active IP Right Cessation
- 1970-03-06 AT AT426771A patent/AT297718B/de not_active IP Right Cessation
- 1970-03-06 AT AT212870A patent/AT297707B/de not_active IP Right Cessation
- 1970-03-06 FR FR7008051A patent/FR2034750B1/fr not_active Expired
- 1970-03-06 CH CH1842872A patent/CH542865A/de not_active IP Right Cessation
- 1970-03-06 NO NO00796/70*[A patent/NO126326B/no unknown
- 1970-03-06 CH CH1842972A patent/CH546778A/xx not_active IP Right Cessation
- 1970-03-07 DE DE2010884A patent/DE2010884C2/de not_active Expired
- 1970-03-09 GB GB01124/70A patent/GB1248727A/en not_active Expired
-
1972
- 1972-10-02 SE SE7212703A patent/SE397832B/xx unknown
-
1974
- 1974-01-03 PH PH15375*A patent/PH10048A/en unknown
- 1974-10-31 PH PH16169A patent/PH11202A/en unknown
-
1975
- 1975-12-30 MY MY10/75A patent/MY7500010A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE2010884C2 (de) | 1982-12-09 |
| SE397832B (sv) | 1977-11-21 |
| NL166023B (nl) | 1981-01-15 |
| FR2034750A1 (xx) | 1970-12-11 |
| DK139973C (xx) | 1979-10-29 |
| CH550812A (de) | 1974-06-28 |
| BE746735A (fr) | 1970-08-17 |
| FR2034750B1 (xx) | 1974-04-12 |
| ES377099A1 (es) | 1972-06-01 |
| CH542865A (de) | 1973-11-30 |
| SE367201B (xx) | 1974-05-20 |
| NL7002884A (xx) | 1970-09-10 |
| AT297718B (de) | 1972-04-10 |
| DK139973B (da) | 1979-05-28 |
| PH11202A (en) | 1977-10-28 |
| GB1248727A (en) | 1971-10-06 |
| MY7500010A (en) | 1975-12-31 |
| JPS4837280B1 (xx) | 1973-11-09 |
| NL166023C (nl) | 1981-06-15 |
| US3907820A (en) | 1975-09-23 |
| CH546778A (de) | 1974-03-15 |
| DE2010884A1 (de) | 1970-12-10 |
| AT297707B (de) | 1972-04-10 |
| PH10048A (en) | 1976-07-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3668241A (en) | Substituted 1-oxoinden-5-yloxy alkanoic acids | |
| US4006180A (en) | [1,3-Dihydroxy-2-substituted and 2,2-disubstituted-indanyloxy(or thio)]alkanoic acids | |
| GB2097387A (en) | 3,4-dihydro-5h-2,3-benzodiazepine derivatives | |
| CS248035B2 (en) | Production method of the(4(oxo-4h)1(-benzopyran-8-yl)carboxyle acides | |
| NO172577B (no) | Fremgangsmaate og mellomprodukter ved fremstilling av substituerte indolinonderivater | |
| NO126326B (xx) | ||
| SU1739848A3 (ru) | Способ получени производных тианафтена или их фармацевтически приемлемых солей | |
| US4376121A (en) | Antiallerigically-active imidazothienopyrimidine derivatives | |
| EP0102175A1 (en) | 5-Oxo-5H-(1)benzopyrano(2,3-b)pyridine derivatives, their production and use | |
| IE49787B1 (en) | Substituted pyrido-(1,2-a)pyrimidines | |
| US3923996A (en) | 3-Substituted-oxindoles in compositions and methods of treating obesity | |
| HU178581B (en) | Process for producing 6-chloro-alpha-methyl-carbasole-2-acetic acid | |
| NO155773B (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 3-substituerte tetrahydropyrrolo (1,2-a) pyrimidinderivater. | |
| KR840000115B1 (ko) | 카바졸 유도체의 제조방법 | |
| US4247715A (en) | 2-Alkynyl-5-indanyloxyacetic acids | |
| US4046772A (en) | Benzodiazepine derivative and process for producing the same | |
| CA1143729A (en) | 3-substituted-hexahydro-pyrimido[1,2-a] azepins, process for the preparation thereof and pharmaceutical compositions containing the same | |
| NO140135B (no) | Fremgangsmaate for fremstilling av d(-)-penicillamin og salter av dette | |
| Juršić et al. | The Selective Methylation of 4-Ethoxycarbonyl-3-Methylpyrazolin-5-One with Dimethyl Sulfate | |
| US3346568A (en) | 2-amino-5-sulfamyl-benzoic acid hydrazides | |
| JPH01113333A (ja) | ３−（４’−ブロモビフェニル−４−イル）テトラリン−１−オンの製造方法 | |
| SU507237A3 (ru) | Способ получени производных азепина или их солей | |
| GB1584863A (en) | 2-carboxyalkyl and 2-carbamoylalkyl-1,3,4-oxadiazole-5-thiols and their preparation | |
| AU2004208873B2 (en) | Methods for producing quinazoline alkaloids | |
| US2748135A (en) | Intermediates for the synthesis of pyridoxine |